PSYG Stock Overview
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Psyence Group Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.035 |
52 Week High | CA$0.17 |
52 Week Low | CA$0.015 |
Beta | 0.21 |
1 Month Change | 16.67% |
3 Month Change | -22.22% |
1 Year Change | -73.08% |
3 Year Change | -90.00% |
5 Year Change | n/a |
Change since IPO | -93.64% |
Recent News & Updates
Recent updates
Shareholder Returns
PSYG | CA Biotechs | CA Market | |
---|---|---|---|
7D | -30.0% | -1.8% | 0.2% |
1Y | -73.1% | -28.6% | 9.0% |
Return vs Industry: PSYG underperformed the Canadian Biotechs industry which returned -28.6% over the past year.
Return vs Market: PSYG underperformed the Canadian Market which returned 9% over the past year.
Price Volatility
PSYG volatility | |
---|---|
PSYG Average Weekly Movement | 43.5% |
Biotechs Industry Average Movement | 13.5% |
Market Average Movement | 8.6% |
10% most volatile stocks in CA Market | 18.5% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: PSYG's share price has been volatile over the past 3 months.
Volatility Over Time: PSYG's weekly volatility (43%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2019 | n/a | n/a | https://www.psyence.com |
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement.
Psyence Group Inc. Fundamentals Summary
PSYG fundamental statistics | |
---|---|
Market cap | CA$6.96m |
Earnings (TTM) | -CA$5.13m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.9x
P/E RatioIs PSYG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PSYG income statement (TTM) | |
---|---|
Revenue | CA$0 |
Cost of Revenue | CA$0 |
Gross Profit | CA$0 |
Other Expenses | CA$5.13m |
Earnings | -CA$5.13m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.037 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did PSYG perform over the long term?
See historical performance and comparison